First Anniversary Milestones and Future Plans WHAT: An update on the Product Quality Research Institutes (PQRI) key events and milestones in its first year and future plans. Learn about the first three research projects that PQRI has adopted to undertake, the fundraising effort underway to support the research projects, and FDAs support for the initiative.
John B. Cox, Executive Director, American Association of Pharmaceutical Scientists (AAPS)
Helen Winkle, Acting Director, Office of Pharmaceutical Sciences, FDA
Kenneth Heimlich, Ph.D., Chair, PQRI Board of Directors
Tobias Massa, Ph.D., Chair, PQRI Steering Committee
National Press Club, First Amendment Room
529 14th Street, NW
Tuesday, December 12 at 10:00 a.m.
The Product Quality Research Institute (PQRI) is a collaborative effort by FDAs Center for Drug Evaluation and Research (CDER), industry and academia to examine and support drug regulatory issues. PQRIs research projects will generate scientific support to reduce regulatory testing and reporting requirements without compromising drug product quality. The institutes recommendations based on this research are expected to speed new drug approvals and reduce the industry's cost for pharmaceutical development. For additional information about PQRI, visit www.pqri.org.
PQRI is administratively managed by AAPS. AAPS is a professional, scientific society of more than 11,000 members employed in academia, industry, government and other research institutes worldwide. Founded in 1986, AAPS aims to advance science through the open exchange of scientific knowledge, serve as an information resource, and con
Contact: Debbie Werfel
American Association of Pharmaceutical Scientists